The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9066956 B1

PDF
Full Text
Expired
Date of Patent:
Jun. 30, 2015

Filed:

Dec. 29, 2011
Applicants:

Frans Ariel Fuentes Garcia, Santiago, CL;

Shu-chen Chen, Santiago, CL;

Marianela Del Carmen Beltran Apablaza, Santiago, CL;

Inventors:
Assignees:

Universidad de Chile, Santiago, CL;

Laboratories Andromaco S.A., Santiago, CL;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/76 (2006.01); A61K 31/42 (2006.01); A61K 31/5685 (2006.01); A61K 9/00 (2006.01); A61K 47/32 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5685 (2013.01); A61K 9/0036 (2013.01); A61K 47/32 (2013.01);
Abstract

Sustained-release vaginal ring for comprising dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate (DHEA-S) or pharmaceutically acceptable thereof as active principle, and optionally a release-modulating agent of the active principle, wherein the amount of active principle is between 1% to 32% by weight, relative to the total weight of the formulation, and the modulator is selected from: polyvinylpyrrolidone K-30, lactose, microcrystalline cellulose and sodium lauryl sulfate. The vaginal ring of the present invention can be used to increase ovarian reserve in women, to be used as drug in assisted reproduction programs, and to relieve symptoms associated with menopause, such as symptoms of vulvar and vaginal atrophy and sexual dysfunction in postmenopausal women.


Find Patent Forward Citations

Fuentes Garcia, Frans. (2015). Vaginal ring comprising dhea or dhea sulfate and optionally a release-modulating agent of the active principle, useful to increase the ovarian reserve in women and to relieve symptoms associated with menopause (U.S. Patent No. 9066956). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9066956

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…